ArticleJapanese journal of radiology2021
Pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19.
Article in Japanese journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 19 citations in OpenAlex.
- Article
- Reversibility of the Enlargement of the Pulmonary Artery in COVID-19 Pneumonia as a Marker of Remission of the Disease.Journal of personalized medicine · 2024Article
- Value of computed tomography pulmonary angiography measurements in predicting 30-day mortality among patients with acute pulmonary embolism.Polish journal of radiology · 2024Article
- Fairness of artificial intelligence in healthcare: review and recommendations.Japanese journal of radiology · 2024Review
- New trend in artificial intelligence-based assistive technology for thoracic imaging.La Radiologia medica · 2023Review
- Pulmonary artery diameter and NT-proBNP in patients with Covid-19: Predicting prognosis and mortality.African health sciences · 2023Article
- The association between pulmonary artery enlargement and mortality in an Emergency Department population undergoing computed tomography pulmonary angiography.Pulmonary circulation · 2023Article
- Can a chest HRCT-based crash course on COVID-19 cases make inexperienced thoracic radiologists readily available to face the next pandemic?Clinical imaging · 2023Article
- Pulmonary Artery Enlargement: An Independent Risk Factor for Mortality in Patients Hospitalized With COVID-19.Mayo Clinic proceedings. Innovations, quality & outcomes · 2022Article
- Letter to the Editor concerning: pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19.Japanese journal of radiology · 2022Article
- Clinical implications of microvascular CT scan signs in COVID-19 patients requiring invasive mechanical ventilation.La Radiologia medica · 2022Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
Abstract
purposeTo describe the prognostic value of pulmonary artery (PA) trunk enlargement on the admission of in-hospital patients with severe COVID-19 infection by unenhanced CT image. MATERIALS AND
methodsIn-hospital patients confirmed COVID-19 from January 18, 2020, to March 7, 2020, were retrospectively enrolled. PA trunk diameters on admission and death events were collected to calculate the optimum cutoff using a receiver operating characteristic curve. According to the cutoff, the subjects on admission were divided into two groups. Then the in-hospital various parameters were compared between the two groups to assess the predictive value of PA trunk diameter.
resultsIn the 180 enrolled in-hospital patients (46.99 ± 14.95 years; 93 (51.7%) female, 14 patients (7.8%) died during their hospitalization. The optimum cutoff PA trunk diameter to predict in-hospital mortality was > 29 mm with a sensitivity of 92.59% and a specificity of 91.11%. Kaplan-Meier survival curves for PA trunk diameter on admission showed that a PA trunk diameter > 29 mm was a significant predictor of subsequent death (log-rank < 0.001, median survival time of PA > 29 mm was 28 days).
conclusionPA trunk enlargement can be a useful predictive factor for distinguishing between mild and severe COVID-19 disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.